Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AZ’ Tagrisso offers sustained benefit in lung cancer

pharmatimesJuly 17, 2018

Tag: Tagrisso , AstraZeneca , Osimertinib , lung cancer

PharmaSources Customer Service